Omnipod Closed Loop Technology to be Compatible with Both Abbott and Dexcom CGMs

Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. 

Sharing Your CGM Data

You don't need to do diabetes alone. If you wear a CGM, read about sharing your data with your friends and family who help you manage Type 2 diabetes.

The Value of Professional CGM

Need help with your diabetes routine? Consider trying professional CGM (P-CGM). You and your doctor can use it to learn more about your Type 2 diabetes.

The Power of Self Advocacy

Advancements in diabetes technology have been amazing over the course of the last decade, but difficulties with insurance companies can make it frustrating to get needs met. This is where self advocacy comes in.

Dash, Tidepool Loop, Horizon: the Future of Omnipod

The Omnipod Dash is now widely available, and two hybrid closed loops, Omnipod Horizon and DASH + Tidepool are expected in the second half of 2020.

One on One With Insulet CEO Shacey Petrovic

Insulet CEO Shacey Petrovic spoke with Beyond Type 1 about her personal connection to T1D, the importance of access, the future of Omnipod and more.

Test Strip Subscription Guide

Test strips can be costly, but you may be able to save money by signing up for a test strip subscription service. Learn about your options here.

FDA Approves First Ready-to-Use Liquid Stable Glucagon Gvoke

On September 10 the FDA approved the Gvoke HypoPen and Gvoke PFS, emergency glucagon rescue devices for the treatment of severe hypoglycemia.

Nasal Glucagon Baqsimi Approved by the FDA

On Thursday, the Food and Drug Administration approved Eli Lilly and Company's Baqsimi, a non-injectable, nasal glucagon and the first of its kind.

ADA 2019 In Review

The biggest diabetes conference of the year — American Diabetes Association’s 79th Annual Scientific Sessions is over, and Beyond Type 2’s editorial staff was reporting live from the conference. Here are the highlights, lowlights, insights, and biggest takeaways from ADA 2019.